The Mobile DNA Conference: Evolution, Diversity, and Impact
June 5–9, 2022
Malahide, Ireland
#DNASRC22
Summary
June 5-9, 2022
The first organized meeting that explicitly focused on mobile DNA and its impact on genomes took place in 1994. At the 2022 FASEB Science Research Conference (SRC) we will celebrate the notable progress in understanding transposon biology and evolution, their contribution to human diseases and normal physiological processes as well as in their wide-spread use as tools for basic science research and clinical applications.
The conference will bring together researchers investigating all aspects of transposable element biology in any organism, ranging from the role transposons play in structural and functional genomics to their causative impact on and therapeutic application to human diseases. Due to the multidisciplinary nature and relevance of our field we also welcome participation of researches interested in aging, cancer, DNA repair, epigenetics, bioinformatics, neurobiology, immunology, evolutionary biology, and developmental biology.
Have questions about the conference? Email us at src@faseb.org.
Program
The main themes of this conference are: 1) 25th anniversary of Sleeping Beauty resurrection and its use for advancing basic science and clinical research; 2) advances in development of wet bench and bioinformatics tools for transposon discovery and annotation across a broad spectrum of organisms; 3) molecular mechanisms of mobilization and its impact on the host with a specific emphasis on aging and age-associated diseases such cancer and neurodegeneration.
Conference sessions will explore the latest findings and promote discussions on:
- Mobile DNA and Human Disease
- Transposons and Aging
- Sleeping Beauty – 25 years of discovery
- Mobile DNA, Epigenetics, and Gene Regulation
- Mechanisms of Mobilization
- Comparative Genomics of Transposable Elements
- Computational tool Use and Development
- Population Genomics of Mobile DNA
The conference will feature nine oral sessions, two poster sessions, two career-development workshops, and a “Meet the Experts” session. The Meet-The-Experts Session will be an informal interaction between participants and selected experts representing research themes featured at the conference.
View the preliminary agenda.
Keynote Lecture
Organizers
Victoria P. Belancio, PhD
David A. Largaespada, PhD
Molly Gale Hammell, PhD
Josefa González, PhD
Steven N. Austad, PhD
Attendees: $1199 + VAT
Students: $1049 + VAT
Invited Speakers: $1199 + VAT
Attendees: $1349 + VAT
Students: $1199 + VAT
Invited Speakers: $1199 + VAT
The registration fee does not include lodging. Please book your lodging through either option below:
Online or by phone at: 00353 845 0000 (Mention “2022 FASEB Conference” for the discounted rate).
Be in the center of activity: Enjoy quick and easy access to all conference functions and networking opportunities.
Additional protection: FASEB may be able to assist you with any issues that arise with the hotel.
Awards
Travel Award Information
The organizing committee will grant at least 33 travel awards ($600 each) that will be applied toward conference registration fees. These awards have been established to offset the cost of conference registration to support the participation of students, postdoctoral trainees, and junior faculty in the Mobile DNA: Evolution, Diversity, and Impact meeting. Those who wish to be considered for a Travel Award must submit an application and abstract by April 25th. Award winners must participate in the entire conference and present a poster. All other things being equal, preference will be given to minority applicants, graduate students, and applicants presenting age-related research. Download information on instructions here.
Platinum Sponsor
Sponsors
_Logo.png?v=637642120704226584){kind=logo}
Funding for this conference was made possible, in part by 1R13 AG074557-01 from the National Institute on Aging. ‘The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.